New insights into membranous glomerulonephritis: from bench to bedside

Anti-Phospholipase A2 Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous Nephropathy

(2011) J. M. Hofstra et al.   Clinical Journal of the American Society of Nephrology

An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis

(2011) E. Hoxha et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

PLA2R Autoantibodies and PLA2R Glomerular Deposits in Membranous Nephropathy

(2011) Hanna Debiec et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab Therapy in Idiopathic Membranous Nephropathy: A 2-Year Study

(2010) F. C. Fervenza et al.   Clinical Journal of the American Society of Nephrology

Autoimmunity in Membranous Nephropathy Targets Aldose Reductase and SOD2

(2010) M. Prunotto et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

In vivo characterization of renal auto-antigens involved in human auto-immune diseases: The case of membranous glomerulonephritis

(2010) Corrado Murtas et al.   Proteomics Clinical Applications

M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous Nephropathy

(2009) Laurence H. Beck et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab for membranous nephropathy and immune disease: less might be enough

(2008) Piero Ruggenenti et al.   Nature clinical practice. Nephrology